TRACON PHARMACEUTICALS INC's ticker is TCON and the CUSIP is 89237H100. A total of 27 filers reported holding TRACON PHARMACEUTICALS INC in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $43,000 | -34.8% | 97,673 | 0.0% | 0.00% | – |
| Q2 2019 | $66,000 | -15.4% | 97,673 | +71.4% | 0.00% | – |
| Q1 2019 | $78,000 | +11.4% | 56,974 | -50.0% | 0.00% | – |
| Q4 2018 | $70,000 | -39.7% | 113,948 | +100.0% | 0.00% | – |
| Q3 2018 | $116,000 | -24.2% | 56,974 | 0.0% | 0.00% | – |
| Q2 2018 | $153,000 | +146.8% | 56,974 | +110.6% | 0.00% | – |
| Q1 2018 | $62,000 | -31.1% | 27,057 | 0.0% | 0.00% | – |
| Q4 2017 | $90,000 | +5.9% | 27,057 | 0.0% | 0.00% | – |
| Q3 2017 | $85,000 | +32.8% | 27,057 | 0.0% | 0.00% | – |
| Q2 2017 | $64,000 | -40.2% | 27,057 | -5.8% | 0.00% | – |
| Q1 2017 | $107,000 | -23.0% | 28,710 | +0.8% | 0.00% | – |
| Q4 2016 | $139,000 | -15.8% | 28,488 | +16.5% | 0.00% | – |
| Q3 2016 | $165,000 | +55.7% | 24,457 | +0.2% | 0.00% | – |
| Q2 2016 | $106,000 | -37.6% | 24,420 | 0.0% | 0.00% | – |
| Q1 2016 | $170,000 | -24.4% | 24,420 | -0.2% | 0.00% | – |
| Q4 2015 | $225,000 | +17.8% | 24,457 | +24.6% | 0.00% | – |
| Q3 2015 | $191,000 | -8.2% | 19,626 | +6.6% | 0.00% | – |
| Q2 2015 | $208,000 | – | 18,417 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| WALL STREET ASSOCIATES | 241,536 | $1,184,000 | 0.78% |
| NEA Management Company, LLC | 2,759,217 | $13,520,000 | 0.54% |
| Eventide Asset Management | 865,526 | $4,241,000 | 0.28% |
| AWM Investment Company, Inc. | 224,153 | $1,098,000 | 0.22% |
| Kinsight, LLC | 21,318 | $104,000 | 0.05% |
| QVT Financial LP | 381,477 | $1,711,000 | 0.05% |
| NEXTHERA CAPITAL LP | 12,714 | $62,000 | 0.04% |
| Perceptive Advisors | 100,000 | $490,000 | 0.04% |
| TFS CAPITAL LLC | 16,753 | $82,000 | 0.02% |
| Candriam S.C.A. | 143,000 | $701,000 | 0.02% |